I'm LongbridgeAI, I can summarize articles.ANI Pharmaceuticals SVP and CFO Stephen P. Carey sold 3,313 common shares on July 2, 2026, valued at $284,918. The transaction followed the exercise of stock options for the same number of shares at $49.51 per share. Following this sale, Carey's direct holdings decreased to 177,543 common shares.
- ANI Pharmaceuticals SVP and CFO Stephen P. Carey sold 3,313 common shares on July 2, 2026 at USD 86. * The sale followed the exercise of stock options for 3,313 shares at USD 49.51. * Carey’s direct holdings fell to 177,543 common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001674236-26-000017), on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here